Monitoring enzyme replacement therapy in Fabry disease--role of urine globotriaosylceramide. (Q45258646)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Monitoring enzyme replacement therapy in Fabry disease--role of urine globotriaosylceramide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

enzyme replacement therapy

8 January 2020

main subject

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Peter J Meikle

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

J Calvin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

S Hogg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

E O'Driscoll

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

D Halsall

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

K Burling

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

G Maguire

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

N Wright

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

T M Cox

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

P B Deegan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

Journal of Inherited Metabolic Disease

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

21-33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15702403%20AND%20SRC:MED&resulttype=core&format=json

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

8 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10545-005-4415-X

A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies

21 January 2018

1 reference

12 December 2020

Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabry disease by tandem mass spectrometry

1 reference

12 December 2020

Fabry disease: fourteen alpha-galactosidase A mutations in unrelated families from the United Kingdom and other European countries

1 reference

12 December 2020

Creatinine assay by a reaction-kinetic principle

1 reference

12 December 2020

Fabry's disease: a multidisciplinary disorder

1 reference

12 December 2020

Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray ionization-tandem mass spectrometry

1 reference

12 December 2020

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

1 reference

12 December 2020

Chemical diagnosis of Fabry's disease by fluorometric assay and fast atom bombardment/mass spectrometry

1 reference

12 December 2020

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

1 reference

12 December 2020

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

1 reference

12 December 2020

Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: implications for the prediction of disease severity

1 reference

12 December 2020

Rapid quantitation of globotriaosylceramide in human plasma and urine: a potential application for monitoring enzyme replacement therapy in Anderson-Fabry disease

1 reference

12 December 2020

Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease

1 reference

12 December 2020

Prevalence of lysosomal storage disorders

1 reference

12 December 2020

Globotriaosylceramide isoform profiles in human plasma by liquid chromatography-tandem mass spectrometry

1 reference

12 December 2020

Immunohistochemical localization of glycosphingolipid in urinary renal tubular cells in Fabry's disease

1 reference

12 December 2020

Immunosurveillance of alglucerase enzyme therapy for Gaucher patients: induction of humoral tolerance in seroconverted patients after repeat administration

1 reference

12 December 2020